A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT04033445 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04033445
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2023-09-19
- Enrollment
- 1064
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.